International

Infarmed withdraws batch of Salofalk medication from the market

Infarmed has suspended the sale of batch L25428A of Salofalk due to serialization irregularities. Patients should consult their doctor before making any changes.

1 September 2026Tagblick Newsdesk

AI-generatedWritten by an AI system, editorially responsible — how we work

Archive photo: Infarmed withdraws batch of Salofalk medication from the market — Archive photoPhoto: The U.S. Food and Drug Administration · Wikimedia Commons · Public domain

Infarmed announced the withdrawal of batch L25428A of Salofalk, which is used for the treatment of intestinal inflammation. The measure was implemented due to a deviation in the product's serialization, raising concerns about its compliance and safety in the market.

Patients currently using this medication have been advised to contact their doctors before making any changes to their treatment. This guidance aims to ensure the health and well-being of patients who rely on Salofalk.

The suspension of sales for this batch of Salofalk highlights the importance of rigorous quality controls in the pharmaceutical industry, especially for medications used for sensitive health conditions.

This item was written by an AI system on the basis of the headlines and short teasers of the independently operating newsrooms named below. We disclose this under Art. 50(4), second subparagraph, of Regulation (EU) 2024/1689 (AI Act). Before publication we check origin and verifiability — anything that appears in only one place is not published — as well as language, substance and legally sensitive content. No separate substantive review of each individual item by a natural person takes place; we therefore do not rely on the exemption in Art. 50(4), second subparagraph, of the AI Act. Editorial responsibility for this publication rests with the person named in the imprint (§ 18 Abs. 2 MStV). Please report errors to [email protected] — we will correct or remove the item. Full reports are available from the sources listed.